SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 944.57 |
Enterprise Value ($M) | 1,911.68 |
Book Value ($M) | 228.84 |
Book Value / Share | 7.27 |
Price / Book | 4.13 |
NCAV ($M) | -977.49 |
NCAV / Share | -31.05 |
Price / NCAV | -0.97 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.05 |
Return on Assets (ROA) | 0.06 |
Return on Equity (ROE) | 0.31 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.95 |
Current Ratio | 1.03 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 457.26 |
Assets | 1,663.59 |
Liabilities | 1,434.75 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 631.45 |
Operating Income | 166.98 |
Net Income | 69.19 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 204.98 |
Cash from Investing | -287.76 |
Cash from Financing | -60.60 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Rubric Capital Management LP | 7.29 | 88.00 | |
13G | Invesco Ltd. | 5.50 | ||
13G | Principal Global Investors | 5.42 | ||
13G | Renaissance Technologies Llc | 5.14 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES | ||
UNITED STATES | ||
UNITED STATES | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
56,053 | 219,271 | 25.56 | |
33,563 | 159,090 | 21.10 | |
78,032 | 317,579 | 24.57 | |
28,386 | 217,244 | 13.07 | |
(click for more detail) |
Similar Companies | |
---|---|
CGEM – Cullinan Therapeutics, Inc. | CGON – CG Oncology, Inc. |
COGT – Cogent Biosciences, Inc. | CPIX – Cumberland Pharmaceuticals Inc. |
CRBU – Caribou Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io